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Abstract
Salmonella is a significant public health burden worldwide and being the 
most common bacterial diarrheal illness among infants and young children. In 
the last few years, Qatar reports a high incidence of salmonellosis outbreaks 
coupled with a significant increase of Multidrug-Resistant (MDR) among 
pediatric populations every year. This study aims to elucidate the molecular 
mechanisms underlying resistance to ceftriaxone, cefepime, amoxicillin-
clavulanate tetracycline, trimethoprim-sulfamethoxazole, chloramphenicol, and 
azithromycin among Salmonella isolated from the pediatric population. A total 
of 246 Salmonella isolates were collected from children under 18 years old 
admitted to the Pediatric Emergency Center (PEC), Hamad Medical Corporation 
(HMC) from Jan. 2018 to Dec 2019 with gastroenteritis. Isolates were tested 
for antibiotic susceptibility against nineteen relevant antibiotics using E-test. 
Resistance was confirmed using PCR-specific primers for 38 genes. Resistance 
was detected against 14 antibiotics, and 38.2% of isolates were resistant to 
at least one antibiotic. Overall, we reported 23.9%, resistance to tetracycline 
21.1%, ampicillin 18.7%, AMC, and 13% sulfamethoxazole-trimethoprim. 
Further, 16.2% of the isolates were Multidrug-Resistant (MDR), with 4.1% 
being Extended-Spectrum β Lactamase (ESBL) producers. 90% of ESBL 
producers harbored one of bla CTX-M-Group. Class 1 AMC resistant samples 
showed the highest resistance to different antibiotics. Our results indicate a high 
antimicrobial resistance pattern of Salmonella and the presence of Class (1) 
cassette that involves the transmission and expression of the resistance among 
AMC resistance isolates, which might lead to increased multi-drug resistance. 
This study provides evidence guidance to activate and implement the pillars 
of an antimicrobial stewardship program in human health to reduce MDR 
salmonellosis.
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Introduction
Salmonella is one of the most common etiological agents of 
foodborne diarrheal illness and typhoid fever worldwide, leading to 
mortality in complicated cases [1]. Importantly, children less than 
5-years old account for approximately a third of deaths attributed 
to foodborne diseases (WHO, 2015). There is an increasing concern 
regarding this pathogen due to the emergence and spread of 
antibiotic-resistance and potentially more pathogenic strains [2]. 
Drug-resistance among gastrointestinal pathogens preferentially 
cause illness in persons receiving antimicrobial drugs for any 
medical condition. Consequently, emerging resistance in foodborne 
pathogens may result in increased burdens of illness and outbreaks 
in settings where patients are treated with antimicrobial drugs [3]. 
Antimicrobial therapy is not indicated in uncomplicated cases 
of gastrointestinal illness in patients without underlying illness. 
However, therapy is needed, and maybe lifesaving in selected patients 
with the prolonged febrile course of suspected underlying invasive 
illness [3]. Non-Typhoidal Salmonella (NTS) can be invasive and 
cause paratyphoid fever, which requires immediate treatment 
with antibiotics. Extended-spectrum cephalosporins being used 
favorably to treat salmonellosis in children [4]. The treatment of 
the Enterobacteriaceae family, including Salmonella, has been 
increasingly complicated by the emergence of resistant strains to first-
line antimicrobial agents [5,6].
The gram-negative bacterial genus Salmonella is divided into 
two species, Salmonella enterica, and Salmonella bongori. Only the 
Salmonella enterica subspecies enterica is of clinical relevance for 
humans [7], and is further classified into more than 2,600 serovars. 
Salmonella can be broadly categorized as typhoidal and Non-
Typhoidal Salmonella (NTS). The typhoidal Salmonella includes 
serovar Typhi, and the closely related serovar Paratyphi (A-C) that 
cause enteric fever [8]. The much larger NTS group causes infectious 
diarrhea worldwide and primarily induces acute, self-limiting 
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gastroenteritis [9]. NTS can also cause various other disorders, 
including bacteremia, meningitis, and osteomyelitis, particularly 
among immunocompromised patients.
Salmonella is emerging as a priority public health hazard in Qatar, 
being the most reported bacterial diarrheal illness among infants 
and young children, alarmingly associated with multiple incidences 
of salmonellosis outbreaks among this pediatric population each 
year. Salmonella is listed among the four commonly isolated 
Enterobacteriaceae from Hamad Medical Corporation (HMC, 
Personal communication). A previous study showed a high incidence 
of salmonellosis in Qatar, especially in children less than five years 
of age, with an overall annual incidence rate ranging between 12.3 
and 30.3 per 100,000 population in 2004-2012 [10]. Nonetheless, this 
previous study does not characterize the molecular level of resistance 
to understand better the relatedness, typing of different isolates, 
and understanding their resistance mechanism. Besides, there are 
no data available after 2012 on salmonellosis incidences in the State 
of Qatar. The spread of resistant bacteria is linked to the misuse of 
antibiotics in human and animal populations and the consumption 
of contaminated food with resistant bacteria [11].
There are limited published data on antibiotic resistance profile 
and its associated genetic determinants in Qatar among Salmonella 
for the pediatric population. Therefore, a study is required to define 
and analyze the antimicrobial resistance and molecular epidemiology 
of Salmonella. Obtaining such information is crucial to tackle and 
mitigate the salmonellosis problem at the clinical, public health, and 
economic levels. The recurrent Salmonella outbreaks in Qatar and the 
increasing number of salmonellosis cases mandate rapid regulatory 
and monitoring reforms at the State level. This study aimed to 
profile the phenotypic resistance of Salmonella to the relevant 
antibiotics. Furthermore, to elucidate the molecular determinants 
underlying resistance to the most worldwide used antibiotics, 
including ceftriaxone, tetracycline, trimethoprim-sulfamethoxazole, 
chloramphenicol, and azithromycin.
This is the first study among Qatar’s pediatric population that 
demonstrates the correlation between genetic and phenotypic trends 
of antimicrobial resistance that would influence the development 
and implementation of stewardship programs to reduce pathogenic 
resistant bacteria’s burden on the community.
Materials and Methods
Clinical isolates
Ethical approval for this study was obtained from the Medical 
Research Centre, HMC, Doha, Qatar, protocol no. MRC-01-17-
198 and Qatar University approval # QU-IBC-2019/008. A total 
of 246 Salmonella isolates were collected between January 2018 
and December 2019 from children (2-18 years of age) of different 
nationalities presented to the Pediatric Emergency Center (PEC), 
HMC, the primary provider of healthcare services in Qatar with 
symptoms mainly, fever and gastroenteritis. For each patient, 
demographic data such as age, nationality, and gender were reported.
Bacterial culture
Pathogens were isolated from human samples using the standard 
bacteriological procedure. Briefly, 1 g of the collected stool samples 
was diluted with 3ml of phosphate-buffered saline (PBS, pH 7.2; 
Sigma, St. Louis, MO, USA), and 500μl of this dilution was added to 
5 ml of Selenite broth (Oxoid, Basingstoke, Hampshire, UK) for the 
enrichment and incubated at 37ºC for 24-48 hr. The enriched samples 
were sub-cultured into MacConkey agar and incubated at 37ºC for 24 
hr. The non-lactose fermenter colonies tested negative with oxidase 
and produced hydrogen sulfide gas were sub-cultured into Hektoen 
Enteric Agar (Biolife-Italia). Suspected colonies (transparent green 
colonies with black centers) except S. paratyphi A, whose colonies 
appear without black centers, were identified by Matrix-Assisted 
laser Desorption/Ionization, MALDI-TOF, (Bruker Daltonik GmbH, 
Leipzig, Germany). On the other hand, blood culture samples were 
incubated on automated BACTEC FX blood culturing instrument 
(B.D., U.S.). Gram stain was performed on blood cultures flagged 
positive. Then, cultured isolates demonstrating Gram-negative 
bacteria were inoculated into MacConkey agar and blood agar. 
Suspected colonies were automatically identified using MALDI-TOF. 
Salmonella serology was performed using (DifcoTM Salmonella O 
Antiserum) and (DifcoTM Salmonella H Antiserum).
Phenotypic antibiotic susceptibility testing
The antibiotic susceptibility testing was conducted using Phoenix 
(the NMIC/ID-5 panel, B. D. Biosciences, Heidelberg, Germany) 
per the manufacturer’s recommendations. This panel includes 15 
antibiotics, namely Amoxicillin/Clavulanic Acid (AMC), Ampicillin 
(AMP), Ceftriaxone (CRO), Aztreonam (ATM), Cefepime (FEP), 
Ceftazidime (CAZ), Meropenem (MEM), Imipenem (IPM), 
Ertapenem (ETP), Piperacillin/tazobactam (TZP), Tigecycline 
(TGC), Ciprofloxacin (CIP), Levofloxacin (LVX) and trimethoprim/
sulfamethoxazole (SXT). At the same time, E-test (Liofilchem, 
Germany) was performed for Azithromycin (AZM), Fosfomycin 
(FOS), Tetracycline (TET), and Chloramphenicol (C) as they were 
not included in the Phoenix automated panel. MICs were interpreted 
according to the guidelines of the Clinical and Laboratory Standards 
Institute CLSI (CLSI, 2017). Escherichia coli ATCC 25922 strain was 
used as a quality control organism. Isolates were confirmed as ESBL 
producers via the Double Disc Synergy Test (DDST) as previously 
described by Eltai et al. [12] AmpC β-lactamase production was 
measured using cefoxitin; a zone diameter of (≥18 mm) was 
considered as AmpC-positive (CLSI, 2017). All intermediate resistant 
isolates were considered susceptible.
Molecular characterization of antibiotic resistance
Whole- genomic DNA was extracted from Salmonella bacterial 
cultures using QIAamp® UCP pathogen Minikit (QIAGEN, 
Germany). Extracted DNA was then used to run PCR for 32 genes 
using previously published primers [11-21]. The conditions used for 
reactions were as follows: PCR mixture was made in the volume of 
20μl containing 0.5μM of each primer, 1μl of DNA, 1× master mix 
(Hot star Taq plus master mix (QIAGEN, Germany) and H2O up to 
20μl. The reaction was amplified in Biometra TAdvanced Thermal 
cycler (Analytik Jena, Germany) under the following conditions: 
initial denaturation at 95ºC for 5 min.; followed by 30 cycles of 30 s 
at 95ºC, 1 min at 44-63 ºC and 90 s at 72ºC and a final extension step 
of 5 min at 72ºC.
The 32 genes that responsible for the resistance of the most 
prescribed antibiotics were amplified. These genes include tet 
A, B, C, D, E and G (Tetracycline resistant isolates), catA, cmlA 
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and floR (Chloramphenicol‐resistant isolates), sul1, sul2 and 
sul3 (Trimethoprim–sulfamethoxazole‐resistant isolates), ESBL 
genes blaTEM, blaCTX-M groups and blaSHV (Third generation 
cephalosporines), mphA, mphB, ermA, ermB, ereA, mefA, and msrA 
(Azithromycin-resistant isolates) and ampC, CMY2 and Class 1 gene 
cassette (Amoxicillin-clavulanate resistant isolates).
The only clear bands were considered for the further fingerprinting 
scoring. The scores’ ‘1’ and ‘’’0’ were given for the presence and 
absence of genes ‘ ‘amplicon’s band, respectively. The data obtained 
by scoring the Antimicrobial Resistance (AMR) genes were subjected 
to cluster analysis. A similarity matrix was constructed using Jaccard’s 
coefficient, where the similarity values were used for cluster analysis. 
Sequential Agglomerative Hierarchical Non-overlapping (SAHN) 
clustering was performed using the Unweighted Pair Group Method 
with the Arithmetic Averages (UPGMA) method. Data were then 
analyzed using Past software version 3.26 [22] based on Hamming 
similarity index with 100 bootstraps.
Statistical analysis
Data were introduced into Microsoft Excel 2010 (Microsoft 
Corporation, New York, USA) to generate figures and run the initial 
analysis. The relation between the resistance, nationality, age, and 
gender grouping was calculated using the Pearson test (GraphPad 
Software, San Diego, California, USA). A probability value (P-value) 
less than 0.05 was considered statistically significant. Past software, 
version 1.91 was used to construct a hierarchical clustering 
dendrogram, and Jacquard’s coefficient was applied to generate the 
similarity values for the cluster analysis.
Results
Demography of the study population
In this study, we tested 246 Salmonella isolates from children 
between 2-18 years of age. Among these, 220 (89.4%) were isolated 
from stool and 26 (10.6%) from blood. The demographic profile of 
the studied population was summarized in Table 1. The male: female 
ratio was 1.4:1 and 194 (78.9%) were under five years of age. The 
Qatari patient comprises 37.4% (n=92) of this study population, while 
other nationalities 62.6%. The typhoidal Salmonella among Qatari 
patient was 30.4%/28 (23 Paratyphi B, 2 Paratyphi A and 3 Typhi) 
and 38.3%/59 (38 Paratyphi B, 5 Paratyphi A and 16 Typhi) among 
non-Qatari. On the other hand non-typhoidal Salmonella isolates 
include 64.6% n= 159 (64 Qatari and 95 non-Qatari) including 
Salmonella group B (n=61), Salmonella group C1 (n=5), Salmonella 
group C2 (n=9), Salmonella group D (n=29), Salmonella group E 
(n=7), Salmonella Choleraesuis (n=8), Salmonella Enteritidis (n=13), 
Salmonella Typhimorium (n=12) and Salmonella group O (n=13).
Phenotypic profile of Salmonella isolates
The antibiotic resistance profile of 246 Salmonella isolates is 
depicted in Figure 1. Resistance was detected against 14 antibiotics. 
38.2% of isolates were resistant to at least one antibiotic. Overall, 
the highest resistance was reported to tetracycline (23.9%) followed 
by (21.1%) ampicillin, (18.7%) AMC, and (13%) trimethoprim-
sulfamethoxazole. The highest phenotypic combination of resistance 
was detected against AMC, AMP, TE & C (4.5%). Furthermore, 16.2% 
of the isolates were Multidrug-Resistant (MDR), with 4.1%being 
ESBL producers (Table 2).
Molecular genotyping profile of Salmonella isolates
Figure 1: Frequency bar chart illustrating Salmonella’s phenotypic resistance profile (n=246) isolated from children (age 2 to 18 years) with gastroenteritis. The 
figure depicts the percentage of isolates with resistance to each of the antibiotics.
AMC: Amoxicillin/Clavulanic Acid; AMP: Ampicillin; CRO: Ceftriaxone; ATM: Aztreonam; FEP: Cefepime; CAZ: Ceftazidime; TZP: Piperacillin/Tazobactam; TGC: 
Tigecycline; CIP: Ciprofloxaci; LVX: levofloxacin; SXT: Trimethoprim/Sulfamethoxazole; AZ: Azithromycin; TET: Tetracycline; C: Chloramphenicol.





Male 46 (50%) 84 (54.5%) 130 (52.8)
Female 46 (50%) 70 (45.5%) 116 (47.2)
Total no./percentage 
(n= 246) 92 (37.4) 154 (62.6) 246 (100)
Age group
5-Feb 74 (80.4%) 120 (78%) 194 (78.9)
18-Jun 18 (19.6%) 34 (22%) 52 (21.1)
Total no./percentage 92 (100) 154 (100) 246(100)
Salmonella species
Non-typhoidal 
Salmonella 64 (69.6%) 95 (61.7%) 159 (64.6)
Typhoidal Salmonella 28 (30.4%) 59 (38.3%) 87 (35.4)
Total no./percentage 92 (100) 154 (100) 246 (100)
Table 1: Demographic profile of the study population (n = 246) with Salmonella 
among pediatric (2 to 18 years old) in the State of Qatar.
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percentage of all other tet genes followed by tetC (8.4%), tetA, tetG 
& tetA 6.8%.
Ten genes underlying ESBL resistance were detected, including 
blaTEM, blaSHV, blaCTX-M-G-1, 2, 3, 8, 9 & 25, and blaCTX-M-14 &15 
(Figure 2B). Nineteen percentage of ESBL isolates harbored blaCTX-
M-Group genes. blaCTX-M-G-8 & 25 and blaSHV were not detected 
among ESBL isolates. While 60% of ESBL isolates were encoded by 
blaTEM gene.
Sul1, sul2, and sul3 were identified among the trimethoprim–
sulfamethoxazole‐resistant isolates (13%, n=32), Figure 2C. Among 
these isolates the most common detected gene was sul2 (84.4%, 
n=27), followed by sul2 (53.1%, n=18), then sul3, (15.6%, n=5/32). 
These sul genes are present as one type or in combination.
Among chloramphenicol resistant isolates (11%, n=27), the most 
predominant gene was floR 44. 4% (n=12), whereas the other genes 
catA and cmlA detected in 37% (n=10) and 11.1% (n=3), respectively. 
(Figure 2D). In addition to two combination, namely cmlA & floR 
and catA & floR, which detected among 3.7% (n=1).
For azithromycin-resistant, seven genes have been detected 
among the isolates mphA, mphB, ermA, ermB, ereA, mefA, and msrA. 
PCR results depicted that 1 of the 11 isolates (MIC ≥ 256 μg/mL) 
harbored mphA genes. The mphB, ermA, ermB, ereA, mefA, and msrA 
genes were negative among all azithromycin-resistant isolates. Class 
(1) gene cassette spotted in (78.5%) isolates. Whereas class 2 gene 
cassette was not detected. Among AMC resistant isolates, 25% (n=12) 
harbored ampC, while only two isolates (4.3%) had CMY2 gene.
Statistical correlation
There was no significant relationship among all the studied 
isolates, between antibiotic resistance, age, gender, and nationality 
variables, through the Pearson test of independence, probability 
value (P>0.05) using (GraphPad Prism version 9.0.2 for Windows, 
GraphPad Software, San Diego, California USA). Calculated 
using the Pearson test, followed by multiple comparisons test was 
performed using Probability value (P>0.05) No significant differences 
were detected by nationality, age, and gender (P>0.05) in relation to 
resistance.
Clustering AMR genes of Salmonella isolates
Cluster analysis was used to study similarity among individual 
of Salmonella isolates that harbored at least one of the studied genes 
(n=73) based on the presence and absence of 24 genes (amp C, CMY 
2, sul 1, sul 2, sul 3, tet A, tet B, tet C, tet D, tet E, tet G, cat A, cml 
A, floR, mph A, bla TEM, bla CTX-M-G1, bla CTX-M-G2, bla CTX-
M-G3, bla CTX-M-G8, bla CTX-M-G9, bla CTX-M-G14, bla CTX-M-G15 
& bla CTX-M-G25). Data were analyzed using an agglomerative 
hierarchical algorithm that revealed forty-three clonal clusters 
among the 73 tested Salmonella isolates. Clonally related strains of 
cluster G1 that harbors only tet A (23.3%, n=17/73) were responsible 
for the predominant tetracycline resistance, followed by A16 (8.2%, 
n=6), which produces a combination of tetA and sul2 type genes that 
express tetracycline and sulfamethoxazole resistance, respectively. 
Sixteen clonal clusters were detected among group A with the main 
cluster A16 followed by cluster A1 producing a combination of three 
genes, sul 1, sul2, and cat A concurrently, then cluster A5 had two 
Resistant phenotype Frequency Percentage %
No resistance 152 61.8
Resistant to only one antibiotic 32 13
AMC, AMP 2 0.8
abAMC, AMP, ATM, FEP, CAZ, CRO, TZP, SXT, 
TE, C 1 0.4
abAMC, AMP, ATM, FEP, CAZ, CRO, TZP, SXT, 
AZ, C 1 0.4
abAMC, AMP, ATM, FEP, CAZ, CRO, TZP, SXT, C 3 1.2
abAMC, AMP, ATM, FEP, CAZ, CRO, TZP, SXT, 
CIP, LVX, C 1 0.4
AMC, AMP, C 1 0.4
abAMC, AMP, CAZ, CRO, TE 1 0.4
AMC, AMP, AZ 1 0.4
bAMC, AMP, FEP, CAZ, CRO, TGC, CIP, LVX, TE 1 0.4
aAMC, AMP, SXT, AZ, C 1 0.4
aAMC, AMP, SXT, C 3 1.2
aAMC, AMP, SXT, CIP, TE 1 0.4
AMC, AMP, SXT 4 1.6
aAMC, AMP, SXT, TE 7 2.8
AMC, AMP, TE 2 0.8
aAMC, AMP, TE, C 11 4.5
abAMP, ATM, FEP, CAZ, CRO, TZP, TE 1 0.4
abAMP, CRO, SXT, CIP, LVX, TE 1 0.4
aAMP, SXT, AZ, C 1 0.4
AMP, TE 1 0.4
CIP, AZ 2 0.8
CIP, LVX 3 1.2
SXT, CIP 1 0.4
aSXT, CIP, LVX, AZ, TE 1 0.4
aSXT, CIP, TE, C 3 1.2
SXT, TE 2 0.8
TE, C 1 0.4
aTGC, CIP, LVX, TE 1 0.4
aTGC, SXT, CIP, TE 1 0.4
TGC, TE 1 0.4
aTZP, TGC, TE 1 0.4
MDR 40 16.2
ESBL 10 4.1
Table 2: Phenotypic resistant profiles of Salmonella isolates from hospitalized 
pediatric in Qatar (n=246).
aMDR multidrug-resistant.
bESBL extended-spectrum beta-lactamase producer.
AMC: amoxicillin/clavulanic acid, AMP: ampicillin, CRO: ceftriaxone, ATM: 
aztreonam, FEP: cefepime, CAZ: ceftazidime, TZP: piperacillin/tazobactam, 
TGC: tigecycline CIP: ciprofloxacin, LVX: levofloxacin, SXT: trimethoprim/
sulfamethoxazole, AZM: azithromycin, TET: tetracycline, C: chloramphenicol.
The detected phenotypic resistance was verified by molecular 
detection of relevant genetic determinants. Tetracycline resistance 
has been confirmed by the existence of tetA, tetB, tetC, tetD, tetE 
& tetG gene (Figure 2A). TetA gene (64.4%) recorded the highest 
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Figure 2: Molecular genotyping profile of antibiotic resistance gene among Salmonella isolated from children with gastroenteritis, representative samples are 
presented. Multiplex PCR was performed for detection of blaCTX-M and Sul group while Uniplex PCR was used for detection of blaSHV, blaTEM, floR, catA, cml and 
tet group; A: tetracyclines resistance detected genes- (tetA, tetB, tetC, tetD, tetE & tetG).
B: Chloramphenicol Resistant detected genes; C: trimethoprim-sulfamethoxazole detected genes; D: detection of blaSHV, blaTEM, and blaCTX-M among ESBL 
producers; M: 1 kb plus ladder marker (Gelpilot, Germany).
combination sul1 & sul2. Group B includes 2 clusters that express a 
combination between tetA, β lactamase and/or ESBL genes. Group 
C consists of four clusters with a combination of tetA, sul, and 
chloramphenicol genes. Group D had seventeen clusters that mainly 
express different tet and chloramphenicol genes.
Discussion
Out of 246 Salmonella isolated from blood and stool samples 
obtained from pediatric patients (2-18 years) who presented with 
gastroenteritis symptoms, 61.8% (n=152) of the isolates exhibit no 
resistance against the tested antibiotics. While 13% (n=32) were 
resistance to only one antibiotics, 4.1% (n=10) were ESBL producers 
and 16.2% (n=40) were MDR.
Tetracycline resistance was the highest observed (24%) among 
the isolates investigated in this study. 64.4% of tetracycline resistance 
isolates harbor the gene tetA, which is often considered part of 
transposon Tn1721. This gene can be associated with conjugative 
and transmissible plasmids with a high capability of moving 
from one bacteria to the other, contributing to the spreading and 
increase of tetracycline resistance [23,24]. Among the 11% (n=27) 
chloramphenicol resistant isolates, floR gene was the most detected 
gene (44.4%, n=12) followed by cat A (37%, n=10) and cmlA gene 
(11.1%, n=3). This agrees with Nogrady et al. [25], who reported that 
(46.4%) of Salmonella isolated from humans in their study harbored 
the floR gene.
Besides, we reported resistance of 21% and 18.7% to ampicillin 
and amoxicillin/clavulanic, respectively. These two antibiotics are 
hugely prescribed to treat respiratory infectious diseases in chickens 
and cattle [26]. This use of antibiotics for therapeutic purposes in 
veterinary medicine and as growth promoters in food-producing 
animals is speculated to be a significant cause of the development of 
resistance in Salmonella, presenting a potential risk to public health 
[27]. The most common genetic determinant of trimethoprim-
sulfamethoxazole resistant isolates was the sul2 gene, which was 
detected among (84.4%, n=27/32), followed by the sul1 gene 53.1% 
(n=18/32) then sul3 15.6% (n=5/32). In contrast to our findings, 
Antunes et al. reported that the sul1 gene was the most prevalent 
gene among Salmonella resistant to sulfamethoxazole [28]. This is 
probably endorsed to the variance in the source of samples wherein 
the previous study; the samples were collected from environmental 
Portuguese Salmonella enterica. The same study reported that 7% of 
Salmonella isolates harbored sul3 gene being the lowest reported as 
in our study.
In this study, 90% (n=10) of the extended cephalosporin-
resistant isolates harbored blaCTX-M genes, in which blaCTX-M-G-1, 
blaCTX-M15, and blaCTX-M-G-3 (50%) were the most common gene. 
However, the bla CTX-M-1 and bla CTX-M -9 groups have also been 
dominant in S. Typhimurium isolates in Shanghai [1]. Our results 
showed that bla CTX-M -9 and 14 were demonstrated by 20% and 
10%, respectively, among ESBL isolates. Most of the ESBL genes are 
usually harbored in a bacterial plasmid, which gives them the ability 
to distribute easily among different bacteria species contributing to 
the increase of antibiotic resistance [29].
Our findings reveal that 11 (4.47%) of the isolates were resistant to 
azithromycin. Food and Drug Administration (FDA) recommended 
using azithromycin to treat invasive Salmonella infections [30] 
because this antibiotic proved an excellent ability to accumulating 
at high intracellular concentrations [31]. Resistant to azithromycin 
were also recorded in other countries [1,30,32]. One high-level 
azithromycin-resistant isolate (MIC ≥256 μg/mL) that harbored 
the mphA gene was identified in our study. This is in line with Phuc 
Nguyen et al. [19], who detected mphA in 34 of 190 Escherichia coli 
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isolated from human feces with MICs 256 mg/L to >1,024 mg/L. 
The resistance against azithromycin among the other ten isolates in 
this study can be underlined by other possible mechanisms, such as 
mutations in the rlpD and rlpV genes [33].
The most common isolated serovar was Salmonella serotyping 
GroupB and Salmonella Paratyphi (24.8%), followed by Salmonella 
serotyping group D (11.8%). This finding contrasts with Iyer et al. 
[34], who reported that Salmonella Typhi was the most abundant 
type of Salmonella spread between children of less than five years but 
in concordance with Ochaia et al. [35], who stated the overall ratio 
of disease caused by Salmonella Typhi to that caused by Salmonella 
Paratyphi is about 10 to 1.
Conclusion
This is the first study to elucidate the genotypic determinants 
of resistance among Salmonella isolates from Qatar’s pediatric 
population. The highest resistance was depicted against tetracycline, 
ampicillin, and amoxicillin-clavulanate. We identified various 
transferrable antimicrobial-resistance genes among the MDR isolates, 
such as ESBLgenes, sul, tet, ampC, cat, cml A & floR genes, and some 
isolates harbored a combination of these genes. The presence of 
these genes poses a considerable threat to the control of Salmonella 
infection locally and globally. Overall, this work provides baseline 
data for the Prevalence of the genetic determinants underlying the 
phenotypic resistance among Qatar’s pediatrics populations. These 
findings can help update the local antimicrobial policy and inform 
the antimicrobial stewardship program to be implemented in health 
Figure 3: Dendrogram of AMR Genes among Salmonella isolates (n=73). 
Agglomerative hierarchical algorithm illustrating the similarity among the 
isolates.
A1: sul1, sul2, cat A (SXT), (C)
A2: ampC, sul1, sul2, cat A (AMC), SXT, C
A3: sul2, cat A SXT, C
A4: sul2 SXT
A5: sul1, sul2 SXT
A6: sul1 SXT
A7: ampC, sul2, cat A, blaTEM, blaCTX-
M-G-1, blaCTX-M-G-3, blaCTX-M-15 AMC, SXT, C, (CRO)
A8: sul2, mph A, cat A, blaTEM, blaCTX-
M-G-1, blaCTX-M-G-3, blaCTX-M-15 SXT, (AZM), C, CRO
A9: amp C, sul1, sul2, catA, blaTEM, 
blaCTX-M-G-1 AMC, SXT, C, CRO
A10: CMY 2, sul2, cat A, blaTEM, blaCTX-
M-G-1 AMC, SXT, C, CRO
A11: tetA, sul1, sul2 (TET), SXT
A12: tetA, tetB, sul1, sul2 TET, SXT
A13: tetA, sul1, sul2, blaCTX-M-G-9, 
blaCTX-M- 14 TET, SXT, CRO
A14: amp C, tetA, sul2 AMC, TET, SXT
A15: amp C, tetA, sul2, cml A, blaCTX-
M-G-9 AMC, TET, SXT, C, CRO
A16: tetA, sul2 TET, SXT
B1: tetA, blaCTX-M-G-3, blaCTX-M-G-15 TET, CRO
B2: CMY 2, tetA, blaTEM AMC, TET, CRO
C1: tetA, sul3, cml A TET, SXT, C
C2: tetA, sul1, sul3, cml A TET, SXT, C
C3: tetA, tetE, sul1, sul3, cml A, floR TET, SXT, C
C4: tetA, sul3 TET, SXT
D1: ampC, tetA, tetB, tetC, tetE, floR AMC, TET, C
D2: tetA, tetB, tetC, tetE, floR TET, C
D3: tetA, tetC, tetE, floR TET, C
D4: tetA, tetC, tetE TET
D5: tetA, tetC, cat A, floR TET, C
D6: tetA, tetC, floR TET, C
D7: amp C, tetA, tetC, floR AMC, TET, C
D8: tetA, tetC TET
D9: amp C, tetA, tetG, floR AMC, TET, C
D10: tetA, tetG, floR TET, C
D11: tetB TET
D12: tetB, floR TET, C
D13: floR C
D14: tetA, floR TET, C
D15: tetA, tetB, tetD TET
D16: tetA, tetC, tetD TET
D17: tetA, tetB TET
E1: tetA, tetE TET
F1: amp C, tetA TET
G1: tetA TET
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